Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
AJR Am J Roentgenol ; 217(4): 959-974, 2021 10.
Article in English | MEDLINE | ID: covidwho-1365501


Neurologic involvement is well-recognized in COVID-19. This article reviews the neuroimaging manifestations of COVID-19 on CT and MRI, presenting cases from the New York City metropolitan region encountered by the authors during the first surge of the pandemic. The most common neuroimaging manifestations are acute infarcts with large clot burden and intracranial hemorrhage, including microhemorrhages. However, a wide range of additional imaging patterns occur, including leukoencephalopathy, global hypoxic injury, acute disseminated encephalomyelitis, cytotoxic lesions of the corpus callosum, olfactory bulb involvement, cranial nerve enhancement, and Guillain-Barré syndrome. The described CNS abnormalities largely represent secondary involvement from immune activation that leads to a prothrombotic state and cytokine storm; evidence for direct neuroinvasion is scant. Comorbidities such as hypertension, complications of prolonged illness and hospitalization, and associated supportive treatments also contribute to the CNS involvement in COVID-19. Routine long-term neurologic follow-up may be warranted, given emerging evidence of long-term microstructural and functional changes on brain imaging after COVID-19 recovery.

Brain Diseases/complications , Brain Diseases/diagnostic imaging , COVID-19/complications , Magnetic Resonance Imaging/methods , Neuroimaging/methods , Tomography, X-Ray Computed/methods , Adult , Brain/diagnostic imaging , Humans , Pandemics , SARS-CoV-2
AJR Am J Roentgenol ; 216(4): 1046-1047, 2021 04.
Article in English | MEDLINE | ID: covidwho-1088880


Among 2820 inpatients with coronavirus disease (COVID-19), 59 (2.1%) underwent brain MRI. Of them, six (10.2%) had MRI findings suspicious for COVID-19-related disseminated leukoencephalopathy (CRDL), which is characterized by extensive confluent or multifocal white matter lesions (with characteristics and locations atypical for other causes), microhemorrhages, diffusion restriction, and enhancement. CRDL is an uncommon but important differential consideration in patients with neurologic manifestations of COVID-19.

Brain/diagnostic imaging , COVID-19/complications , Leukoencephalopathies/etiology , Magnetic Resonance Imaging/methods , Pandemics , SARS-CoV-2 , Adult , Aged , Aged, 80 and over , COVID-19/epidemiology , Female , Humans , Leukoencephalopathies/diagnosis , Male , Middle Aged , Retrospective Studies
Neurology ; 95(10): 454-457, 2020 09 08.
Article in English | MEDLINE | ID: covidwho-616669